Initial screening and retest mode in apheresis platelet donors: a comparative analysis
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 3
Abstract
Objective To investigate the effectiveness of current indicators in initial screening and retest before donation and access the optimal testing strategies. Methods Data of initial screening (rate method for ALT, colloidal gold method for HBsAg) and retest (rate method for ALT, ELISA for HBsAg) of 18 510 platelet donors in our center from January 2019 to December 2021 were collected, and the results were retrospectively analyzed and compared in terms of different years and number of donations. Results From 2019 to 2021, data of initial screening and retest of platelet donors were as follows: 1) the deferral rate of ALT and HBsAg was 12.98% (2 403/18 510) vs 0.26%(40/15 412); 2) the deferral rate of ALT was 13.19% (712/5 398) vs 0.20%(9/4 410)in 2019, 13.33% (873/6 549) vs 0.06%(3/5 387)in 2020 and 11.05% (725/6 563) vs 0.07%(4/5 615)in 2021; for initial screening, significant difference was noticed in ALT reactivity in 2021 as in comparison to other two years(P<0.05); 3) the reactive rate of HBsAg was 0.43% (23/5 398) vs 0.18%(8/4 410)in 2019, 0.66% (43/6 549) vs 0.20%(11/5 387)in 2020 and 0.41% (27/6 563) vs 0.09%(5/5, 615) in 2021. For initial screening, HBsAg deferral in 2021 was significantly different from 2019, while similar with 2020. 4) Among ALT deferral samples in the retest, 68.75% (11/16) were ALT≥45 U/L. Among HBsAg reactive samples, 91.67% (22/24) were reactive by single reagent. Conclusion Setting the threshold value of ALT for platelet donors in initial screening as less than 45 U/L can effectively reduce the reactive rate in the retest. HBsAg screening only for first-time platelet donors can reduce the detection cost. Adding pre-donation detection indicators according to local prevalence of transfusion transmitted diseases is conductive to reduce the discarding rate of platelets.
Authors and Affiliations
Yuanfeng CHEN, Xiaoling WU, Aiping ZHAO
Keywords
Related Articles
- EP ID EP738502
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.03.003
- Views 59
- Downloads 0
Research progress on platelet rich plasma in management of patients with knee osteoarthritis
Knee osteoarthritis (KOA) is a common chronic degenerative disease of cartilage, which often occurs in middle-aged and elderly patients. It can cause joint swelling, pain and limited movement. With the aging population g...
Chinese expert consensus on standardized application of automation technology for transfusion compatibility testing
Given the increasingly widespread application of automation technology in transfusion compatibility testing, in order to reduce the systemic and hidden risks of automated testing equipment, to provide guidance for the st...
Correlation between type Ⅱ CD36 deficiency and intron polymorphism
Objective To study the correlation between type ⅡCD36 deficiency and the polymorphism of intron sequence. Methods A total of 516 random healthy platelet donors from Liaoning Blood Center were involved: 241 of them were t...
HBV laboratory tests and demographic characteristics in 169 897 first-time blood donors
Objective To investigate the HBV infection markers detection and demographic characteristics of first-time blood donors, so as to provide evidence for blood donor recruitment. Methods HBsAg was detected by ELISA, HBsAg n...
Analysis of common statistical problems in blood transfusion medical research papers
High-quality scientific research papers need the support of correct and rigorous statistical methods. However, many papers in transfusion medicine research have problems with the improper use of statistical methods. This...